Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials by Sawitzki, B, Harden, PN, Reinke, P, Hester, JL, Issa, F, Morris, PJ, Bushell, A, Friend, PJ, Wood, KJ

Freezing medium containing 5% DMSO enhances the cell viability and recovery rate after cryopreservation of regulatory T cell products ex vivo and in vivo by Kaiser, D, Otto, NM, McCallion, O, Hoffmann, H, Zarrinrad, G, Stein, M, Beier, C, Matz, I, Herschel, M, Hester, J, Moll, G, Issa, F, Reinke, P, Roemhild, A

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients. by Bestard, O, Crespo, E, Stein, M, Lúcia, M, Roelen, D, de Vaal, Y, Hernandez-Fuentes, M, Chatenoud, L, Wood, K, Claas, F, Cruzado, J, Grinyó, J, Volk, H, Reinke, P

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials by Sawitzki, B, Harden, PN, Reinke, P, Roberts, ISD, Hester, J, van der Net, JB, Petchey, W, Issa, F, Morris, PJ, Bushell, A, Friend, P, Wood, K, Geissler, EK, Et al.